|
Global Womens Gathering - About Us
Global Womens Gathering: offers resources and information on business, timeline, dates, economic, events, global, historical, important, major, political, timeline, what happened, women
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
Summary
GBI Research, the leading business intelligence provider, has released its latest resear ...
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
Summary
GBI Research, the leading business intelligence provider, has released its latest research "Endpoints - Clinical Trials i ...
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Mar
NEW YORK, Nov. 28, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Summary
GBI Research's report, "Orphan Auto ...
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the
NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Summary
GBI Research, ...
Advanced Drug Delivery Systems: Technologies and Global Markets
NEW YORK, Nov. 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Advanced Drug Delivery Systems: Technologies and Global Markets
REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for drug delivery, including the market as seen by the end users of the different applications of drug delivery.
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011
NEW YORK, Nov. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011
Summary
GlobalData's "Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011" report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financing in the medical ...
Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011
NEW YORK, Nov. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011
Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011
Summary
GlobalData's "Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011" report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry.
China Banking Intermediary Business Report, 2011
NEW YORK, Nov. 2, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
China Banking Intermediary Business Report, 2011
In H1 2011, the operating revenue of China's 16 listed banks reached RMB 1.09 trillion, of which intermediary business revenue amounted to RMB218.691 billion, up 45.96% YoY and sharing 20.18% of total revenue.
|
 |
|
Loading
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
Summary
GBI Research, the leading business intelligence provider, has released its latest research "Endpoints - Clinical Trials i ...
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011
NEW YORK, Nov. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011
Summary
GlobalData's "Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011" report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financing in the medical ...
Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011
NEW YORK, Nov. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011
Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011
Summary
GlobalData's "Power Quarterly Deals Analysis - M&A and Investment Trends, Q3 2011" report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry.
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
Summary
GBI Research, the leading business intelligence provider, has released its latest resear ...
Advanced Drug Delivery Systems: Technologies and Global Markets
NEW YORK, Nov. 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Advanced Drug Delivery Systems: Technologies and Global Markets
REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for drug delivery, including the market as seen by the end users of the different applications of drug delivery.
China Banking Intermediary Business Report, 2011
NEW YORK, Nov. 2, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
China Banking Intermediary Business Report, 2011
In H1 2011, the operating revenue of China's 16 listed banks reached RMB 1.09 trillion, of which intermediary business revenue amounted to RMB218.691 billion, up 45.96% YoY and sharing 20.18% of total revenue.
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Mar
NEW YORK, Nov. 28, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Summary
GBI Research's report, "Orphan Auto ...
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the
NEW YORK, Nov. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Summary
GBI Research, ...
|
 |
|